Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives
Tiffani J. Mungoven, Luke A. Henderson, Noemi Meylakh
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Applying a biopsychosocial model to migraine: rationale and clinical implications
Chiara Rosignoli, Raffaele Ornello, Agnese Onofri, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 78
Central Sensitization in Migraine: A Narrative Review
Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 2673-2682
Open Access | Times Cited: 47
Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
Hyoung Cheol Lee, Soohyun Cho, Byung‐Kun Kim
Neurological Sciences (2023) Vol. 44, Iss. 7, pp. 2455-2463
Closed Access | Times Cited: 26
Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 13
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Hugo Sevivas, Paula Fresco
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial
Ruth Meise, Gabriela Ferreira Carvalho, Christian Thiel, et al.
Cephalalgia (2023) Vol. 43, Iss. 2
Open Access | Times Cited: 20
Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
Kofi Frimpong-Manson, Yuma T. Ortiz, Lance Richard McMahon, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8
Four Decades of Occipital Nerve Stimulation for Headache Disorders: A Systematic Review
Linda Kollenburg, Erkan Kurt, Wim M. Mulleners, et al.
Current Pain and Headache Reports (2024) Vol. 28, Iss. 10, pp. 1015-1034
Closed Access | Times Cited: 6
The Epigenetics of Migraine
Farzin Zobdeh, Иван Иванович Еременко, Mikail A. Akan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9127-9127
Open Access | Times Cited: 14
Subgroups of pelvic pain are differentially associated with endometriosis and inflammatory comorbidities: a latent class analysis
Marzieh Ghiasi, Chi Chang, Amy L. Shafrir, et al.
Pain (2024) Vol. 165, Iss. 9, pp. 2119-2129
Closed Access | Times Cited: 5
Using optical coherence tomography and optical coherence tomography angiography to delineate neurovascular homeostasis in migraine: a review
Devahuti R. Chaliha, Mauro Vaccarezza, Jason Charng, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Neuroimmunological effects of omega-3 fatty acids on migraine: a review
Ting‐Bin Chen, Cheng‐Chia Yang, I‐Ju Tsai, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4
Association of ESR1 Polymorphisms with Susceptibility to Migraine: A Meta-Analysis and Trial Sequential Analysis
Shovit Ranjan, Akshita Paikaray, Ankur Mishra, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access
Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial
Astrid Hjelholt, Flemming W. Bach, Helge Kasch, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320937-e0320937
Open Access
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review
Antonio Russo, Luigi Francesco Iannone, Ilaria Orologio, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 192-192
Open Access
Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years
Antonio Santoro, Andrea Fontana, Massimiliano Copetti, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 208-208
Open Access
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, et al.
Toxins (2023) Vol. 15, Iss. 6, pp. 364-364
Open Access | Times Cited: 10
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
Simona Guerzoni, Carlo Baraldi, Flavia Lo Castro, et al.
Brain and Behavior (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 9
Mechanism and clinical use of botulinum neurotoxin in head and facial region
Swarnalakshmi Raman, Yumiko Yamamoto, Yoshitaka Suzuki, et al.
Journal of Prosthodontic Research (2023) Vol. 67, Iss. 4, pp. 493-505
Open Access | Times Cited: 7
Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
Yazan Bader, Reem Suliman, Mohamad Harb, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1683-1693
Open Access | Times Cited: 7
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
Adriana Della Pietra, Juha R. Savinainen, Rashid Giniatullin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 12
A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache
Licia Grazzi, Alberto Raggi, Erika Guastafierro, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 21, pp. 14116-14116
Open Access | Times Cited: 12
The Influence of Vitamin D3 Administration on the Levels of CGRP, Glutamate, and NLRP3 during the Ictal Phase in Chronic Migraine Patients
Restu Susanti, Yuliarni Syafrita, Afriwardi Afriwardi A, et al.
Pharmacognosy Journal (2024) Vol. 15, Iss. 6, pp. 1052-1058
Open Access | Times Cited: 2
Secondary Trigger Point Deactivation Surgery for Nerve Compression Headaches: A Scoping Review
Sara Saffari, Tiam M. Saffari, Jeffrey E. Janis
Plastic & Reconstructive Surgery Global Open (2024) Vol. 12, Iss. 2, pp. e5620-e5620
Open Access | Times Cited: 2
Rare GPR37L1 Variants Reveal Potential Association between GPR37L1 and Disorders of Anxiety and Migraine
Gerda E. Breitwieser, Andrea Cippitelli, Yingcai Wang, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 19, pp. e1226232024-e1226232024
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top